The Global Mometasone Furoate Market was valued at USD 1.24 Billion in 2024 and is projected to reach USD 2.08 Billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period (2025–2032). This growth is being driven by the increasing global prevalence of inflammatory skin disorders such as eczema and psoriasis, rising cases of allergic rhinitis and asthma, and the expanding availability of generic and advanced formulations.

As the pharmaceutical industry focuses on effective and safe corticosteroid treatments, the spotlight is on the key API manufacturers and formulators who are driving production, innovation, and global supply. In this blog, we profile the Top 10 Companies in the Global Mometasone Furoate Industry—a mix of established pharmaceutical giants and specialized API producers shaping the future of this essential therapeutic compound.

---

🔟 10. Hangzhou Longshine Bio-Tech Co. Ltd.

Headquarters: Hangzhou, Zhejiang, China
Key Offering: Mometasone Furoate API, Pharmaceutical Intermediates

Hangzhou Longshine Bio-Tech is a significant Chinese supplier of high-purity mometasone furoate active pharmaceutical ingredient (API). The company serves both domestic and international markets, emphasizing cost-effectiveness and scalability in its manufacturing processes to meet the growing demand for generic corticosteroid APIs.

Strategic Focus:

• Expansion of GMP-certified production capacity
• Focus on competitive pricing for emerging markets
• Strengthening supply chain partnerships in the Asia-Pacific region

Download FREE Sample Report: Global Mometasone Furoate Market – View in Detailed Research Report

---

9️⃣ 9. New Hualian Pharmaceutical Co. Ltd.

Headquarters: Taizhou, Zhejiang, China
Key Offering: Mometasone Furoate API and Finished Dosage Forms

New Hualian Pharmaceutical is an integrated player involved in the synthesis of mometasone furoate API and the development of finished formulations. The company leverages vertical integration to control quality and cost, making it a key supplier for generic pharmaceutical companies worldwide.

Strategic Focus:

• Investment in advanced crystallization and purification technologies
• Development of combination therapies incorporating mometasone
• Targeting regulatory approvals in Latin American and African markets

---

8️⃣ 8. Xianju Pharmaceutical Co. Ltd.

Headquarters: Xianju, Zhejiang, China
Key Offering: Mometasone Furoate API (Various Grades)

Xianju Pharmaceutical is a major global exporter of corticosteroid APIs, including mometasone furoate. The company’s large-scale manufacturing capabilities and adherence to international pharmacopoeial standards (USP, EP) have positioned it as a critical source for generic drug manufacturers.

Strategic Focus:

• Supplying approximately 22% of the Asia-Pacific region’s mometasone API demand
• Continuous process optimization to reduce production costs
• Building long-term contracts with multinational generic companies

---

7️⃣ 7. Anuh Pharma Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Mometasone Furoate API, Steroid Intermediates

Anuh Pharma, part of the Aristo Pharma Group, is a prominent Indian manufacturer of steroid APIs. The company has a strong focus on mometasone furoate, with a significant portion of its output exported to regulated markets, supported by robust quality systems and regulatory filings.

Strategic Focus:

• Expanding DMF (Drug Master File) registrations in the US and Europe
• Focus on niche, high-value steroid APIs
• Enhancing R&D for impurity profiling and analytical methods

Download FREE Sample Report: Global Mometasone Furoate Market – View in Detailed Research Report

---

6️⃣ 6. Avik Pharmaceutical Ltd.

Headquarters: Ahmedabad, Gujarat, India
Key Offering: Mometasone Furoate API (Including Novel Formulations)

Avik Pharmaceutical is recognized for its technological expertise in developing and manufacturing complex steroid APIs. The company is investing in advanced drug delivery systems, including patented nano-emulsion technologies for mometasone furoate to enhance bioavailability and topical efficacy.

Strategic Focus:

• Pioneering novel delivery mechanisms for dermatological applications
• Strategic partnerships with formulation companies for value-added products
• Strong emphasis on R&D for next-generation corticosteroid formulations

---

5️⃣ 5. Symbiotec Pharmalab Pvt. Ltd.

Headquarters: Indore, Madhya Pradesh, India
Key Offering: Mometasone Furoate, Mometasone Furoate Monohydrate API

Symbiotec Pharmalab is a leading global manufacturer of steroid hormones and APIs. The company gained significant competitive edge with its FDA-approved Mometasone Furoate Monohydrate, a specific crystalline form offering stability advantages, making it a preferred supplier for high-quality generic formulations.

Strategic Focus:

• Leadership in specialized steroid forms like monohydrate
• Expanding manufacturing footprint with new, dedicated production lines
• Focus on stringent quality control for regulated markets

---

4️⃣ 4. Hovione

Headquarters: Lisbon, Portugal
Key Offering: High-purity Mometasone Furoate API, Particle Engineering Services

Hovione is a multinational, integrated CDMO (Contract Development and Manufacturing Organization) with expertise in complex API manufacturing. The company provides mometasone furoate API alongside value-added services like particle size engineering, which is crucial for inhalation and topical product performance.

Strategic Focus:

• Leveraging particle technology to optimize drug delivery for nasal sprays and inhalers
• Strong regulatory support and filings for clients in the US and EU
• Sustainable and efficient manufacturing processes at its global sites

---

3️⃣ 3. Aarti Industries Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Mometasone Furoate API and Key Intermediates

Aarti Industries is a diversified specialty chemicals company with a major presence in pharmaceutical intermediates and APIs. In 2024, the company commissioned a dedicated, state-of-the-art production line for mometasone furoate at its Gujarat facility, significantly boosting its capacity to serve the global market.

Strategic Focus:

• Backward integration for key raw materials ensures supply security and cost control
• Strategic focus on scaling production to meet rising generic demand
• Commitment to environmentally sustainable manufacturing practices

Download FREE Sample Report: Global Mometasone Furoate Market – View in Detailed Research Report

---

2️⃣ 2. Teva Pharmaceutical Industries Ltd.

Headquarters: Tel Aviv, Israel
Key Offering: Mometasone Furoate API, Generic Finished Dosage Forms (Nasal Spray, Creams)

As one of the world’s largest generic pharmaceutical companies, Teva is a powerhouse in the mometasone furoate market. The company controls a substantial portion of the API supply and markets numerous branded generic formulations globally. A recent $35 million expansion of its Spanish API facility aims to increase mometasone capacity by 40%.

Strategic Focus:

• Vertical integration from API to finished product
• Aggressive pursuit of first-to-file generic opportunities in major markets
• Portfolio expansion with combination products and new delivery systems

---

1️⃣ 1. Cipla Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Mometasone Furoate API and a Wide Range of Formulations (Nasal Sprays, Creams, Ointments)

Cipla Ltd. is a global leader in the mometasone furoate landscape, renowned for its extensive portfolio and vast distribution network spanning over 80 countries. The company’s deep expertise in respiratory and dermatology segments drives its dominant position. Its dermatology business, heavily supported by mometasone products, reported a 12% year-on-year growth in FY2024, underscoring its market strength.

Strategic Focus:

• Market leadership through a comprehensive brand portfolio (e.g., Momate, Nasoclear)
• Strong focus on affordable access in emerging and developed markets alike
• Continuous investment in R&D for new formulations and combination therapies to address unmet patient needs

Get Full Report Here: Global Mometasone Furoate Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Mometasone Furoate is Precision and Accessibility

The mometasone furoate market is evolving beyond traditional generic competition. While cost-effective API supply remains crucial, the industry’s future is being shaped by innovation in drug delivery, expansion into underserved regions, and the development of smarter therapeutic combinations.

📈 Key Trends Shaping the Market:

• Rapid API capacity expansion in India and China to meet global generic demand
• Innovation in formulation technologies (nanoparticles, improved bases) for better efficacy and compliance
• Strategic penetration into high-growth emerging markets in Asia-Pacific and Africa
• Increasing development of fixed-dose combination products to enhance therapeutic value and extend commercial life

Get Full Report Here: Global Mometasone Furoate Market – View in Detailed Research Report

The companies listed above are not only supplying a critical therapeutic molecule—they’re advancing the science of corticosteroid treatment to improve patient outcomes worldwide.